Loading the section…
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 30/04/2026 | 31/10/2025 | 31/07/2025 | 30/04/2025 | 31/10/2024 | 31/07/2024 |
|---|---|---|---|---|---|---|
| Revenue | 53M | 47M | 35M | 35M | 32M | 28M |
| Cost of revenue | 40M | 36M | 26M | 26M | 24M | 22M |
| Gross profit | 12M | 11M | 9M | 9M | 7M | 7M |
| Research and development | 87,000 | 80,000 | 55,000 | 73,000 | 155,000 | 93,000 |
| Selling, general and administrative | 10M | 10M | 7M | 8M | 6M | 5M |
| Operating expenses | 10M | 10M | 7M | 8M | 7M | 5M |
| Operating income | 3M | 823,000 | 2M | 2M | 563,000 | 2M |
| Pre-tax income | — | — | — | — | 538,000 | 2M |
| Income tax | 577,000 | 186,000 | 368,000 | 280,000 | 128,000 | 401,000 |
| Net income | 2M | 540,000 | 1M | 1M | 410,000 | 1M |
| Earnings per share | 0.05 | 0.01 | 0.03 | 0.03 | 0.01 | 0.03 |
| Earnings per share, diluted | 0.05 | 0.01 | 0.03 | 0.03 | 0.01 | 0.03 |
| Weighted average shares | 41M | 40M | 38M | 38M | 38M | 37M |
| Weighted average shares, diluted | 43M | 42M | 40M | 39M | 39M | 40M |
| Metric | 30/04/2026 | 31/01/2026 | 31/10/2025 | 31/07/2025 | 30/04/2025 | 31/01/2025 | 31/10/2024 | 31/07/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 24M | 20M | 18M | 9M | 12M | 7M | 9M | 7M |
| Receivables | 13M | 13M | 11M |
| Metric | 30/04/2026 | 31/10/2025 | 31/07/2025 | 30/04/2025 | 31/10/2024 | 31/07/2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | 5M | — | — | 6M | — | — |
| Depreciation and amortisation | 1M | 962,000 | 583,000 | 554,000 |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 7M |
| 6M |
| 8M |
| 9M |
| 8M |
| Inventory | 9M | 10M | 10M | 6M | 5M | 5M | 3M | 3M |
| Current assets | 49M | 45M | 41M | 23M | 24M | 22M | 22M | 20M |
| Goodwill | 9M | 9M | 9M | 9M | 9M | 9M | 9M | 9M |
| Total assets | 88M | 86M | 84M | 51M | 53M | 47M | 48M | 43M |
| Current liabilities | 21M | 21M | 22M | 15M | 19M | 17M | 19M | 14M |
| Total liabilities | 32M | 33M | 34M | 22M | 26M | 22M | 25M | 21M |
| Equity | 55M | 53M | 50M | 30M | 26M | 25M | 23M | 22M |
| Shares outstanding | 41M | 41M | 41M | 38M | 38M | 38M | 38M | 37M |
| Shares issued | 41M | 41M | 41M | 38M | 38M | 38M | 38M | 38M |
| Treasury shares | 230,000 | 230,000 | 230,000 | 230,000 | 230,000 | 230,000 | 230,000 | 230,000 |
| 314,000 |
| 314,000 |
| Share-based compensation | 580,000 | — | — | 305,000 | — | — |
| Capital expenditure | 177,000 | — | — | 539,000 | — | — |
| Investing cash flow | −177,000 | — | — | −539,000 | — | — |
| Financing cash flow | −372,000 | — | — | −605,000 | — | — |